CD5 and diffuse large B-cell lymphoma: Relatively few literature findings suggest worse clinical outcomes in individuals with CD5-positive DLBCL due to resistance to treatment.[3] The lack of understanding in this area encourages more investigation into this particular type of lymphoma.